- Continued investments in regulatory costs despite potential regulatory relief.Seminar announcement featuring former White House Counsel Kathryn Ruemmler
1 duplicate copy in the archive
Title Match
Case Filed-34526House OversightBofA Merrill Lynch Research Report Disclaimer and Compliance Notice
November 11, 20254p
Case File
d-34526House OversightBofA Merrill Lynch Research Report Disclaimer and Compliance Notice
Other
The passage consists entirely of standard legal and compliance boilerplate for a research report, containing no specific allegations, names, transactions, or actionable leads linking influential actor Mentions BofA Merrill Lynch and its research affiliates (MLPF&S). References short‑selling restrictions, regulatory regimes, and conflict‑of‑interest policies. Contains generic warnings about legal,
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #014423
Pages
4
Persons
0
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.